Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Aclaris Therapeutics
ACRS
$869M
| $1.81M | ﹤0.01% |
1,182,737
+393,140
| +50% | +$839K |
|
3077
Traeger
COOK
$172M
| $1.81M | ﹤0.01% |
21,540
-87
| -0.4% | -$9.63K |
|
3078
MediWound
MDWD
$185M
| $1.81M | ﹤0.01% |
116,508
+17,798
| +18% | +$318K |
|
3079
Personalis
PSNL
$1.51B
| $1.81M | ﹤0.01% |
514,176
+16,083
| +3% | +$76.4K |
|
3080
Idaho Strategic Resources
IDR
$557M
| $1.8M | ﹤0.01% |
125,723
+7,589
| +6% | +$93.3K |
|
3081
Fate Therapeutics
FATE
$326M
| $1.79M | ﹤0.01% |
2,269,609
+42,642
| +2% | +$52.3K |
|
|
CAN
3082
Canaan Creative
CAN
$159M
| $1.79M | ﹤0.01% |
2,042,741
+633,443
| +45% | +$1.01M |
|
|
THRD
3083
DELISTED
Third Harmonic Bio
THRD
| $1.79M | ﹤0.01% |
514,887
+33,028
| +7% | +$160K |
|
3084
Ramaco Resources Class B
METCB
$408M
| $1.79M | ﹤0.01% |
264,614
+39,781
| +18% | +$334K |
|
3085
BRC Group Holdings
RILY
$289M
| $1.78M | ﹤0.01% |
459,736
+23,570
| +5% | +$107K |
|
3086
Monopar Therapeutics
MNPR
$799M
| $1.77M | ﹤0.01% |
48,540
+9,944
| +26% | +$358K |
|
|
PAMT
3087
PAMT Corp
PAMT
$297M
| $1.76M | ﹤0.01% |
145,344
+1,809
| +1% | +$26.1K |
|
3088
Destination XL Group
DXLG
$35.4M
| $1.76M | ﹤0.01% |
1,206,274
-29,528
| -2% | -$69.1K |
|
3089
Epsilon Energy
EPSN
$173M
| $1.76M | ﹤0.01% |
249,177
+6,168
| +3% | +$40.3K |
|
3090
United States Antimony
UAMY
$1.02B
| $1.76M | ﹤0.01% |
799,473
+10,745
| +1% | +$18.6K |
|
3091
Criteo S.A. Ordinary Shares
CRTO
$923M
| $1.76M | ﹤0.01% |
49,655
-2,774
| -5% | -$108K |
|
3092
NewAmsterdam Pharma
NAMS
$3.34B
| $1.76M | ﹤0.01% |
85,828
-2,716
| -3% | -$60.4K |
|
3093
Finance of America Companies
FOA
$198M
| $1.75M | ﹤0.01% |
82,243
+3,120
| +4% | +$76.3K |
|
3094
American Outdoor Brands
AOUT
$157M
| $1.75M | ﹤0.01% |
143,481
+4,587
| +3% | +$70.4K |
|
3095
LifeVantage
LFVN
$85.3M
| $1.74M | ﹤0.01% |
119,058
+2,467
| +2% | +$46.5K |
|
3096
Enlight Renewable Energy
ENLT
$11.9B
| $1.74M | ﹤0.01% |
107,384
+1,327
| +1% | +$22.2K |
|
3097
ReNew
RNW
$2.25B
| $1.73M | ﹤0.01% |
292,962
-26,365
| -8% | -$170K |
|
3098
Aemetis
AMTX
$124M
| $1.72M | ﹤0.01% |
989,485
+54,492
| +6% | +$116K |
|
3099
Expensify
EXFY
$245M
| $1.72M | ﹤0.01% |
566,147
+21,467
| +4% | +$74.6K |
|
|
TE
3100
T1 Energy
TE
$1.63B
| $1.72M | ﹤0.01% |
1,362,590
-670
| -0% | -$1.24K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.